G. Pilianidis, G. . Papanastasiou, P. . Tikoudi, A. . Themistocleous, G. . Farmakis, and K. . Dolianitis, “Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?”, EJCRIM, vol. 11, no. 3, Feb. 2024.